Consensus statement on the use of clozapine during the COVID-19 pandemic

作者：Dan Siskind, William G. Honer, Scott R. Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert S. Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F.J. Schulte, David Taylor, Hélène Verdoux, Amanda Wheeler, Oliver Freudenreich · 发表于：Journal of Psychiatry and Neuroscience · 年份：2020 · DOI：10.1503/jpn.200061 · 被引用次数：160 · 研究领域：Schizophrenia research and treatment、Mental Health Treatment and Access、Psychiatric care and mental health services

With the ongoing coronavirus disease 2019 (COVID-19) pandemic, psychiatrists find themselves in the clinical situation of being asked by patients, family members and patient advocacy societies to help ensure access to clozapine as a medication critical for ongoing patient care. To provide clozapine